Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,164
Total Claims
$1.3M
Drug Cost
1,428
Beneficiaries
$897
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-20%
Cost per patient vs peers
$897 vs $1,128 avg
+8%
Brand preference vs peers
9.1% vs 8.4% avg
Brand vs Generic
Brand: 1,363 claims · $982K
Generic: 13,668 claims · $281K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 119 | $158K |
| Dulaglutide | 47 | $105K |
| Apixaban | 107 | $97K |
| Sitagliptin Phos/Metformin Hcl | 56 | $66K |
| Empagliflozin | 42 | $62K |
| Semaglutide | 50 | $59K |
| Linagliptin | 44 | $46K |
| Insulin Glargine,hum.Rec.Anlog | 63 | $40K |
| Dolutegravir Sodium/Lamivudine | 13 | $35K |
| Atorvastatin Calcium | 1,635 | $29K |
| Dapagliflozin Propanediol | 25 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $24K |
| Rivaroxaban | 15 | $20K |
| Sacubitril/Valsartan | 11 | $16K |
| Rosuvastatin Calcium | 479 | $14K |
Prescribing Profile
Patient Profile
72
Avg Age
61%
Female
1.87
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data